Humatica AG was retained to advise Capvis on its majority investment in Austrian firm AMANN GIRRBACH AG, a pioneer in dental CAD/CAM technology. The firm is a leading innovator in the field and a full-service provider for digital dental prosthetics.
Humatica provided organisational due diligence services for this transaction.
To view press release: Humatica advises Capvis on their recent investment in AMANN GIRRBACH
2024 was a milestone year for private equity, and for Humatica. The industry is under greater pressure to generate acceptable returns than ever before. With…
Read moreWe are pleased to announce Humatica’s expansion in the United States following a long history of successful project delivery there from Europe. This marks a…
Read moreHumatica’s Andros Payne provided expert insights into leveraging organizational effectiveness for value creation at this year’s Private Equity Insights DACH Conference in Munich. Leaders play…
Read more